SGLT-2 inhibitor use not linked to increased risk for UTI events
(HealthDay)—Initiation of therapy with sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes mellitus is not associated with an increased risk for urinary tract infection (UTI) events compared with initiation ...
Jul 30, 2019
0
4